37
Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence Center Genesis Health System 2016 Genesis Research Summit June 8, 2016 Adler Education Center Genesis Medical Center, Davenport (East Campus)

Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Sleep Apnea Research

Jon H. Lemke, Ph.D. Chief Biostatistician

Jordan Brautigam, MHA Business Analyst

Business Intelligence Center Genesis Health System

2016 Genesis Research Summit June 8, 2016

Adler Education Center Genesis Medical Center, Davenport (East Campus)

Page 2: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 2

Page 3: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Sleep Apnea Research Outline

Study Purpose and Goals

Study Design

Outcomes

Impact on Patient Care

5/25/2016 Lemke, GHS Business Intelligence Center 3

Page 4: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

National Perspective ALL 41 Institutes in NIH claim diagnosis and treatment of

sleep apnea is crucial to their mission.

The Joint Commission issues an Alert Friday June 26, 2015

Incidence of Sentinel Events have an abundance of potential sleep apnea patients.

Recommend screening patients for sleep apnea upon admission to the hospital to identify patients at greater risk for sentinel adverse events.

At Genesis we have been doing this since November 2012. Sleep disordered breathing has a different footprint on across ALL major diagnostic categories.

5/25/2016 Lemke, GHS Business Intelligence Center 4

Page 5: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 5

Anesthesiologist Perspective “Practice Guidelines for the Perioperative Management of Patients

with Obstructive Sleep Apnea” (2006)

Focus: “Patients with OSA who may be at increased risk for perioperative morbidity and mortality because of potential difficulty in maintaining a patent airway”(1082).

Recommendations: “Anesthesiologists should work with surgeons to develop a protocol whereby patients in whom the possibility of OSA is suspected on clinical grounds are evaluated long enough before the day of surgery to allow preparation of perioperative management”(1084).

“A physical examination should include an evaluation of the airway, nasopharyngeal characteristics, neck circumference, tonsil size…”(1084).

“The consultants agree that perioperative use of CPAP or NIPPV may improve the perioperative condition of patients who they believe are at increased risk from OSA…”(1084).

“Because of their propensity for airway collapse and sleep deprivation, patients at increased perioperative risk from OSA are especially susceptible to the respiratory depressant and airway effects of sedatives, opioids, and inhaled anesthetics” (1085).

Page 6: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Selected Previous Research Undiagnosed and Untreated Sleep Apnea patients with

knee or hip replacement were 9 times more likely to have unplanned visits to ICU.

Gupta R, Parvizi, J, Hanssen A, Gay P. Postoperative Complications in Patients with Obstructive Sleep Apnea Syndrome Undergoing Hip or Knee Replacement: A Case-Control Study. Mayo Clin Proc. 2001;76:897-905.

32% increase (from 37% to 49%) of Left Ventricular Ejection Fraction (LVEF) after one month of PAP use; results reversed after one week without PAP.

Bradley T, Floras J. Sleep Apnea and Heart Failure: Part 1: Obstructive Sleep Apnea. Circulation 2003;107:1671-1678.

Schneider Trucking with comprehensive diagnosis and treatment had 74% reduction in accidents and 91% reduction in hospitalizations.

Lazar RA. An Emerging Standard of Care Requiring Commercial Driver Screening for Sleep Apnea: Practical Considerations and Risk Management Strategies for the Trucking Industry. White Paper Published August 1, 2007.

5/25/2016 Lemke, GHS Business Intelligence Center 6

Page 7: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Adherent - but

5/25/2016 Lemke, GHS Business Intelligence Center 7

Page 8: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Sleep Apnea Risk Groups

3. No Dx-Likely Sleep Apnea

4. No Dx-Unlikely to have Sleep Apnea

1. Dx-Adherent

2. Dx-Nonadherent

4/13/2016 Lemke, GHS Business Intelligence Center 8

Page 9: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Caveats Biases exist in this screening as we primarily depend upon

what the patient tells us.

We are only analyzing those that come to the hospital, and cannot compare them to those that are not hospitalized. In these analyses the focus is entirely on the “Inpatient” encounters.

Changes in demographics of the population, access to care, definitions and documentation are changing who is a hospitalized “Inpatient”.

Some inpatients are screened by self report at one GMC site, transferred and then observed at another GMC site.

Several of these slides focus on the first 2.0 years of encounters.

4/13/2016 Lemke, GHS Business Intelligence Center 9

Page 10: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

4/13/2016 Lemke, GHS Business Intelligence Center 10

Page 11: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

4/13/2016 Lemke, GHS Business Intelligence Center 11

Page 12: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Competing Risks: Physician Documented Prevalences with MIDAS+ Cluster Ranking

by Sleep Apnea Status

Sleep Apnea Risk Group

Arthroplasty Total Knee

Heart Failure Septicemia PTCA Viral

Pneumonia

Dx – Adherent 1st

(8.2%) 4th

(5.1%) 2nd

(6.6%) 3rd

(5.3%) 6th

(4.6%)

Dx – Nonadherent 6th

(3.9%) 1st

(6.9%) 2nd

(6.9%) 3rd

(5.7%) 4th

(5.3%)

No Dx – Likely 9th

(2.5%) 4th

(4.2%) 1st

(6.7%) 2nd

(5.6%) 3rd

(5.3%)

No Dx – Unlikely 2nd

(5.4%) 5th

(3.3%) 1st

(6.1%) 4th

(3.9%) 3rd

(4.8%)

4/13/2016 Lemke, GHS Business Intelligence Center 12

Page 13: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Focus on 44,924 Acute Care Inpatients Sleep Apnea Status by Site

Sleep Apnea Risk Group

Davenport Silvis Aledo DeWitt Total:

Dx – Adherent 4,437

(12.6%) 687

(7.6%) 34

(10.3%) 25

(7.0%) 5,183

(11.5%)

Dx – Nonadherent 4,334

(12.3%) 903

(10.0%) 44

(13.4%) 63

(17.7%) 5,344

(11.9%)

No Dx – Likely 4,464

(12.7%) 997

(11.1%) 31

(9.4%) 47

(13.2%) 5,539

(12.3%)

No Dx – Unlikely 22,012 (62.5%)

6,406 (71.2%)

220 (66.9%)

220 (62.0%)

28,858 (64.2%)

Total 35,247 (100%)

8,993 (100%)

213 (100%)

255 (100%)

44,924 (100%)

4/13/2016 Lemke, GHS Business Intelligence Center 13

Page 14: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Comparison of Sleep Apnea Risk Groups by Sex Dx of Sleep Apnea

(Group 1 + 2)

No Dx of Sleep Apnea

(Group 3 + 4)

Total

Male 5,915 (27.9%) 15,320 (72.1%) 21,235 (100%)

Female 4,612 (19.5%) 19,077 (80.5%) 23,689 (100%)

Total 10,527 (23.4%) 34,397 (76.6%) 44,924 (100%)

Dx-Adherent

(Group 1)

Dx-Nonadherent

(Group 2)

Total

Male 3,068 (51.9%) 2,847 (48.1%) 5,915 (100%)

Female 2,115 (45.9%) 2,497 (54.1%) 4,612 (100%)

Total 5,183 (49.2%) 5,344 (50.8%) 10,527 (100%)

No Dx – Likely

(Group 3)

No Dx – Unlikely

(Group 4)

Total

Male 2,290 (19.3%) 9,586 (80.7%) 11,876 (100%)

Female 2,072 (14.1%) 12,650 (85.9%) 14,722 (100%)

Total 4,362 (16.4%) 22,236 (83.6%) 26,598 (100%)

4/13/2016 Lemke, GHS Business Intelligence Center 14

Page 15: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

4/13/2016 Lemke, GHS Business Intelligence Center 15

Page 16: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

4/13/2016 Lemke, GHS Business Intelligence Center 16

Page 17: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

4/13/2016 Lemke, GHS Business Intelligence Center 17

Page 18: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Current Research Team Investigators

Jon H. Lemke

Desyree Weakley

Stephen C. Rasmus

Vicki Loving

Tosha Allen

Mike Malloy

Brian Dirksen

Mikel O’Klock

Neil Flynn

9/25/2015 Lemke, GHS Business Intelligence Center 18

Page 19: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Special Thanks Maja Zingmark

Hannah McAfoos

Ryan Kelly

Chris Lynn

Dr. Claudy

Gina Gore

Candice Elias

Tami Gumpert

Braxton Lancial

Alyssa Barkalow

Lynn Colberg

Dianna Paustian

Amanda Wesson

Every Physician and Every Nurse who has had a frank discussion about sleep apnea.

All of the Sleep Techs

All of the Respiratory Techs

9/25/2015 Lemke, GHS Business Intelligence Center 19

Page 20: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 20

Page 21: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 21

Page 22: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 22

Page 23: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 23

Page 24: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 24

Page 25: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Acute Inpatient Complications by Sleep Apnea Status 2013-2015 (18+)

0.00

25.00

50.00

75.00

100.00

125.00

150.00

175.00

200.00

Observedper 1000

Expectedper 1000

5/25/2016 Lemke, GHS Business Intelligence Center 25

Sleep Apnea Status

O:E Ratio

Delta (O-E)

Excess to

Target

Adherent 1.04 24.9 115.5

Nonadherent 1.19 163.7 273.7

Likely 1.38 258.6 346.5

Unlikely 1.33 1111.0 1546.6

All 1.28 1558.1 2282.3

Page 26: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 26

Page 27: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 27

Page 28: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 28

Page 29: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 29

Page 30: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Acute Inpatient Mortality by Sleep Apnea Status 2013-2015 (18+)

0.00%

0.50%

1.00%

1.50%

2.00%

2.50%

3.00%

ObservedPercent

ExpectedPercent

5/25/2016 Lemke, GHS Business Intelligence Center 30

Sleep Apnea Status

O:E Ratio

Delta (O-E)

Excess to

Target

Adherent 0.88 -11.73 0.97

Nonadherent 0.98 -2.36 14.59

Likely 0.89 -15.37 2.75

Unlikely 0.81 -127.02 -41.61

All 0.85 -156.47 -23.29

Page 31: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 31

Page 32: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 32

Page 33: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

5/25/2016 Lemke, GHS Business Intelligence Center 33

Page 34: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Sleep Apnea Status with Maximum O:E Ratio by Most Frequent MDC

System/Disease Complications Mortality ALOS Readmission

Circulatory Unlikely Likely Nonadherent Nonadherent

Musculoskeletal Likely Likely Likely Likely

Respiratory Likely Nonadherent Likely Adherent

Digestive Likely Nonadherent Likely Likely

Infectious and Parasitic

Likely Nonadherent Likely Adherent

Nervous System Nonadherent Nonadherent Nonadherent Unlikely

Kidney and Urinary Tract

Nonadherent Nonadherent Likely Nonadherent

Endocrine, Nutr., Metabolic

Adherent Likely Unlikely Unlikely

4/13/2016 Lemke, GHS Business Intelligence Center 34

Page 35: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

4/13/2016 Lemke, GHS Business Intelligence Center 35

Page 36: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Conclusions Benefits of No Diagnosis or Nonadherence?

More likely to visit the hospital for nonelective reasons

More likely to stay longer

More like to have complications

More likely to code

More likely to have an unplanned visit to the ICU

More likely to die in the hospital

More likely to get inpatient status benefits

Hmm, and for everyone?

Higher motor vehicle insurance premiums

Higher healthcare insurance premiums

Unnecessary loss of friends and family 5/25/2016 Lemke, GHS Business Intelligence Center 36

Page 37: Sleep Apnea Research - Genesis Health System · 2016. 6. 12. · Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan Brautigam, MHA Business Analyst Business Intelligence

Conclusions You must know the sleep apnea status of each

patient to anticipate complications, rapid responses, code blues, unplanned ICU transfers, serious safety events, sentinal events, … .

In peer reviews of cases it is crucial to ask about a patients sleep apnea status.

Expect the unexpected for people with untreated sleep apnea!

The success of any ACO is dependent upon how well the health system deals with sleep apnea!

Be grateful to each person with sleep apnea who is an adherent CPAP user!

4/13/2016 Lemke, GHS Business Intelligence Center 37